Bristol-Myers Squibb Company (BMY) Stock Price: $56.48+0.91 (+1.64%)
The total return cagr for Bristol-Myers Squibb Company (BMY) stock is 21.06% over the past 12 months. The 3 year average growth rate is 0.06% and the 5 year cagr is 1.10%. Total return includes dividends reinvested.
The closing share price for Bristol-Myers Squibb Company (BMY) stock was $56.48 for Tuesday, June 9, 2026, up +1.64% from the previous day.
BMY Price Chart
BMY Key Metrics
See All MetricsBMY Earnings Preview
Next Earnings Date
Jul 30, 2026
51 days away
EPS Estimate
1.61
Revenue Est.
$11.70B
Last Quarter Results
EPS
$1.58
vs Estimate
$1.42
Revenue
$11.49B
vs Estimate
$10.93B
BMY Analyst Ratings
Consensus Rating
Based on 25 analysts
Average Price Target
$63.08
+11.7% upside
Low
$40.00
Current
$56.48
High
$75.00
BMY Analyst Estimates
Earnings Per Share (EPS) Estimates
Quarterly
| Period | Low | Avg | High | # Analysts |
|---|---|---|---|---|
| Q1 2027 | N/A | $1.38 | N/A | 6 |
| Q2 2027 | N/A | $1.55 | N/A | 6 |
| Q3 2027 | N/A | $1.53 | N/A | 6 |
| Q4 2027 | N/A | $1.55 | N/A | 6 |
Annual
| Period | Low | Avg | High | # Analysts |
|---|---|---|---|---|
| FY 2027 | N/A | $6.14 | N/A | 17 |
| FY 2028 | N/A | $5.39 | N/A | 9 |
Revenue Estimates
Quarterly
| Period | Low | Avg | High | # Analysts |
|---|---|---|---|---|
| Q1 2027 | N/A | $10.91B | N/A | 6 |
| Q2 2027 | N/A | $11.43B | N/A | 6 |
| Q3 2027 | N/A | $11.60B | N/A | 6 |
| Q4 2027 | N/A | $12.05B | N/A | 6 |
Annual
| Period | Low | Avg | High | # Analysts |
|---|---|---|---|---|
| FY 2027 | N/A | $46.30B | N/A | 17 |
| FY 2028 | N/A | $40.98B | N/A | 9 |
Source: FMP Analyst Consensus Estimates. Forward P/E calculated using average EPS estimate for the nearest fiscal year.
BMY Competitors' Key Metrics
| Stock | Market Cap | Close Price | Price Change | TTM Total Return | 5Y CAGR | 10Y CAGR |
|---|---|---|---|---|---|---|
| 1BMY | $115.34B | $56.48 | +1.64% | +21.06% | +1.10% | +0.95% |
BMY Charts
Valuation Charts
Performance Charts
CAGR Charts
Financial Statement Charts
- Revenue
- Gross Profit
- Operating Income
- Net Income
- EBITDA
- Free Cash Flow
- Operating Cash Flow
- Capital Expenditure
- Acquisitions
- Share Buybacks
- Stock-Based Compensation
- Total Assets
- Total Equity
- Cash & Equivalents
- Accounts Receivable
- Inventory
- PP&E
- Goodwill
- Accounts Payable
- Retained Earnings
- Total Debt
- Long-Term Debt
- Short-Term Debt